End Points Must Be Clinically Meaningful for Drug Development in Nonalcoholic Fatty Liver Disease
- PMID: 26602217
- DOI: 10.1053/j.gastro.2015.11.017
End Points Must Be Clinically Meaningful for Drug Development in Nonalcoholic Fatty Liver Disease
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
